Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells

Oncology Reports

Volumn 35, Issue 6, 2016, Pages 3696-3704

  Medina Aguilar, Rubiceli ^a   Marchat, Laurence A ^b   Ocampo, Elena Arechaga ^c   Gariglio, Patricio ^a   Mena, Jaime García ^a   Sepúlveda, Nicolás Villegas ^a   Castillo, Macario Mart Ínez ^a   López Camarill, César ^d  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

Author keywords

AURKA; BRCA1; Breast cancer; Cell cycle; PLK1; Resveratrol; Transcriptome

Indexed keywords

AURORA A KINASE; BRCA1 PROTEIN; BUB1 RELATED PROTEIN; CELL CYCLE PROTEIN 6; COMPLEMENT COMPONENT C5; CYCLIN B1; CYCLIN D1; CYTOCHROME P450 1B1; DICKKOPF 1 PROTEIN; FATTY ACID TRANSPORTER 4; GLUCOSE TRANSPORTER 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 18; INTERLEUKIN 24; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICROTUBULE ASSOCIATED PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 6; NOGO A ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; POLO LIKE KINASE 1; PROTEIN MLH1; PROTEIN MSH2; RESVERATROL; RHO KINASE INHIBITOR; SERUM AMYLOID A; SLIT PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN; ANTINEOPLASTIC AGENT; AURKA PROTEIN, HUMAN; BRCA1 PROTEIN, HUMAN; CCNB1 PROTEIN, HUMAN; CCND1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; STILBENE DERIVATIVE; TRANSCRIPTOME;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CELL MOTION; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AURORA KINASE A; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN B1; CYCLIN D1; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MCF-7 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; STILBENES; TRANSCRIPTOME;

EID: 84964867587     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4728     Document Type: Article

References (28)

1. Le Corre L, Chalabi N, Delort L, Bignon YJ and Bernard-Gallon DJ: Resveratrol and breast cancer chemoprevention: Molecular mechanisms. Mol Nutr Food Res 49: 462-471, 2005.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386, 2015.
3. Wang Y, Wang Z, Qi Z, Yin S, Zhang N, Liu Y, Liu M, Meng J, Zang R, Zhang Z, et al: The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Mol Cancer 13: 94, 2014.
4. McInnes C and Wyatt MD: PLK1 as an oncology target: Current status and future potential. Drug Discov Today 16: 619-625, 2011.
5. Sun JM, Yang LN, Xu H, Chang B, Wang HY and Yang G: Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells. Am J Cancer Res 5: 1133-1145, 2015.
6. Vundru SS, Kale RK and Singh RP: β-Sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells. BMC Complement Altern Med 13: 280, 2013.
7. Singh CK, George J and Ahmad N: Resveratrol-based combinatorial strategies for cancer management. Ann NY Acad Sci 1290: 113-121, 2013.
8. Yuan L, Zhang Y, Xia J, Liu B, Zhang Q, Liu J, Luo L, Peng Z, Song Z and Zhu R: Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells. Mol Med Rep 11: 2459-2464, 2015.
9. Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G, Gariglio P, et al: Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 8: E64378, 2013.
10. Su D, Cheng Y, Liu M, Liu D, Cui H, Zhang B, Zhou S, Yang T and Mei Q: Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. PLoS One 8: E54505, 2013.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real- Time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408, 2001.
12. In K, Park J and Park H: Resveratrol at high doses acts as an apoptotic inducer in endothelial cells. Cancer Res Treat 38: 48-53, 2006.
13. Vanamala J, Reddivari L, Radhakrishnan S and Tarver C: Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10: 238, 2010.
14. Alkhalaf M, El-Mowafy A, Renno W, Rachid O, Ali A and Al-Attyiah R: Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch Med Res 39: 162-168, 2008.
15. Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, et al: Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat 130: 387-398, 2011.
16. Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia J, Liu J, Chen N, Li M and Zhu R: Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S phase cell cycle arrest and apoptosis through caspase/cyclin CDK pathways. Mol Med Rep 10: 1697-1702, 2014.
17. García-Zepeda SP, García-Villa E, Díaz-Chávez J, Hernández-Pando R and Gariglio P: Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur J Cancer Prev 22: 577-584, 2013.
18. Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM, et al: Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget 6: 7774-7787, 2015.
19. Pan B, Zheng S, Liu C and Xu Y: Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell. Mol Biol Rep 40: 27-33, 2013.
20. Chen Y, Li D and Li S: The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell Cycle 8: 3488-3492, 2009.
21. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B and Fernandez-Salguero PM: The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: Cell-specific alteration of the cell cycle. Biochem Pharmacol 64: 1375-1386, 2002.
22. Meeran SM and Katiyar SK: Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 13: 2191-2202, 2008.
23. León-Galicia I, Díaz-Chávez J, García-Villa E, Uribe-Figueroa L, Hidalgo-Miranda A, Herrera LA, Alvarez-Rios E, Garcia-Mena J and Gariglio P: Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. Eur J Cancer Prev 22: 11-20, 2013.
24. Lee SY, Jang C and Lee KA: Polo-like kinases (plks), a key regulator of cell cycle and new potential target for cancer therapy. Dev Reprod 18: 65-71, 2014.
25. Li Y, Zhang DY, Ren Q, Ye F, Zhao X, Daniels G, Wu X, Dynlacht B and Lee P: Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching. Mol Cell Biol 32: 2454-2466, 2012.
26. Fustier P, Le Corre L, Chalabi N, Vissac-Sabatier C, Communal Y, Bignon YJ and Bernard-Gallon DJ: Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer 89: 168-172, 2003.
27. Zou J, Rezvani K, Wang H, Lee KS and Zhang D: BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress. Cell Cycle 12: 2255-2265, 2013.
28. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002.